×

[Editorial] Robotic surgery evaluation: 10 years too late

During 2003–13, the number of radical prostatectomies done with the robot-assisted laparoscopic technique increased from about 1·8% to 85% in the USA despite the lack of high level evidence comparing robotic surgery to the standard, cheaper, open technique. In this issue of The Lancet John Yaxley and colleagues report the early outcomes of the first randomised trial comparing these two techniques and find no difference in quality of life outcomes at 12 weeks. The final results are awaited with interest.

[Correspondence] Global surgery initiative in Greece: more than an essential initiative

Conditions that are treated primarily or frequently with surgery constitute a substantial portion of the global disease burden. At the same time, development of safe, essential, life-saving surgical and anaesthesia care in low-income and middle-income countries has stagnated or regressed.1 In 2012, injuries caused nearly 5 million deaths and 270 000 women died from complications during pregnancy. Many of these injury-related and obstetric-related deaths, as well as deaths cause by abdominal emergencies, could be prevented by improved access to surgical care.

[Seminar] Hyperthyroidism

Hyperthyroidism is characterised by increased thyroid hormone synthesis and secretion from the thyroid gland, whereas thyrotoxicosis refers to the clinical syndrome of excess circulating thyroid hormones, irrespective of the source. The most common cause of hyperthyroidism is Graves’ disease, followed by toxic nodular goitre. Other important causes of thyrotoxicosis include thyroiditis, iodine-induced and drug-induced thyroid dysfunction, and factitious ingestion of excess thyroid hormones. Treatment options for Graves’ disease include antithyroid drugs, radioactive iodine therapy, and surgery, whereas antithyroid drugs are not generally used long term in toxic nodular goitre, because of the high relapse rate of thyrotoxicosis after discontinuation.

[Perspectives] Shengshou Hu: leader of cardiac surgery and health reform in China

“Wise man finds pleasure in streams”, says an old Chinese saying. Being at one with water has always been part of Chinese cardiac surgeon Shengshou Hu’s life, from the wide waters of the Yangtze river to the swimming pool close to his professional home today in Beijing, where he is President of Fuwai Hospital, affiliated with the Chinese Academy of Medical Sciences. “As a young man, swimming across the Yangtze river with its strong currents seemed a good metaphor for life, and even today I find swimming a good time for reflection and relaxation, especially after surgery”, he says.

Insurers pick wrong target in war on health costs

AMA President Dr Michael Gannon has accused the major private health funds of “squeezing” patients, doctors and hospitals in pursuit of ever-greater profits.

Hitting back at Medibank Private claims that “market failure” in the health system was driving up the cost of care, particularly some surgical procedures, Dr Gannon denied do doctors were forcing up costs and instead blamed insurers for forcing more of the expense on to patients and providers.

“Insurers are trying to contain costs everywhere, and it’s very difficult for the Government and the industry if the industry is in profit mode,” the AMA President told The Australian. “They are looking to cut costs wherever it is possible and there are reasonable and appropriate ways in which they can do that, and there are other ways which involve squeezing doctors, squeezing hospitals and squeezing patients.”

Dr Gannon said costs were being driven by a mix of factors including the cost of prostheses, rising wages, technological advances, soaring drug prices and an ageing population, which meant that patients were increasingly presenting with a complexity of health problems.

But he said there was little evidence that doctors were responsible for driving up costs.

Dr Gannon said that while international comparisons were important, and it was understandable that Medibank was looking to contain its costs, the fact was that the “vast majority” of operations were provided at no direct cost to the patient.

He said that 86 per cent of operations involved no gap payment, and a further 7 per cent included a known gap of less than $500. Doctor fees typically accounted for between 5 and 7 per cent of the cost of elective surgery in a private hospital.

“So, when we look at the increase in the costs year-on-year in private health care, the doctor’s fee represents a very small part of that. The doctor’s fee is very rarely the issue,” he said.

Medibank Private Executive General Manager Dr Andrew Wilson has used a three-year-old report showing that Australians were paying among the highest costs in the world for cataract surgery and knee and hip replacement as evidence of market failure that was making the nation’s health system internationally uncompetitive.

Dr Wilson said patients were being denied access to the information needed to assess whether or not the prices they were being charged represented good value for money, such linking specialist fees with clinical outcomes.

“While such data undoubtedly exists, it is unavailable to consumers, leaving them with little information to make informed decisions on medical specialists – a classic example of market failure,” the Medibank executive said.

But the same study, the 2013 Comparative Price Report prepared by the International Federation of Health Plans (IFHP), showed for many common procedures such as childbirth, appendectomy and angioplasty, costs in Australia were comparable with those of most other developed economies, and well below those charged in the US.

It found that hospital costs per day in Australia were almost half of those charged in New Zealand and less than a third of the US cost, charges for MRIs and CT scans were moderate by international standards, while the normal delivery of a baby cost on average US$6623, compared with US$8307 in Switzerland and US$10,002 in the US.

Australian Private Hospitals Association Chief Executive Michael Roff accused Medibank of being “in a time warp” in its search for figures to justify Dr Wilson’s claims.

Mr Roff said cost comparisons in 2013 had been distorted by the strength of the Australian dollar against the US currency, and more recent 2015 data showed “Australia is indeed competitive based on the IFHP analysis, and is not the most expensive country by any measure”.

This included figures showing the cost of cataract surgery in Australia was 16 per cent cheaper than in the US last year, and was also lower than in the United Kingdom, he said.

Dr Gannon said all had an interest in ensuring the health system delivered value for money.

“It’s in the interest of all of us to look at good stewardship, reduce complication rates, contain costs where possible, that’s in the interests of everyone because ultimately it’s the taxpayers of Australia that foot these bills,” he said. “The doctor’s fee is a small part of the issue, but we want to work with Government, with insurers, to make sure that Australian taxpayers and, especially those who put their hand in their pocket for private health insurance, get really good value for money.”

Adrian Rollins

  

[Series] Serving transgender people: clinical care considerations and service delivery models in transgender health

The World Professional Association for Transgender Health (WPATH) standards of care for transsexual, transgender, and gender non-conforming people (version 7) represent international normative standards for clinical care for these populations. Standards for optimal individual clinical care are consistent around the world, although the implementation of services for transgender populations will depend on health system infrastructure and sociocultural contexts. Some clinical services for transgender people, including gender-affirming surgery, are best delivered in the context of more specialised facilities; however, the majority of health-care needs can be delivered by a primary care practitioner.

Australia’s hospitals 2014–15 at a glance

Australia’s hospitals 2014–15 at a glance provides summary information on Australia’s public and private hospitals. In 2014–15, there were 10.2 million hospitalisations, including 2.5 million involving surgery. Public hospitals provided care for 7.4 million presentations to emergency departments, with 74% of patients seen within recommended times for their triage category and about 73% completed within 4 hours. This publication is a companion to the 2014–15 Australian hospital statistics suite of publications.

Contaminated mouth wash recalled

A common mouth wash and denture cleaner has been recalled after being blamed for a rash of infections among intensive care patients at a hospital.

Batches of Chlorofluor Gel, which is taken to help treat mouth infections and is often used as a post-operative treatment following teeth extraction and other oral surgery, have been found to be heavily contaminated with a bacteria that can cause serious infections in patients with chronic lung diseases such as cystic fibrosis.

The Therapeutic Goods Administration has called on all those with Chlorofluor Gel from with a batch number BK 119 to immediately stop using the preparation, and distributor Professional Dentist Supplies has undertaken a nationwide recall of the product.

The TGA said the contamination was discovered after a group of intensive care patients at an unnamed hospital were found to be colonised or infected with the bacterium Burkholderia cepacia.

Investigations found that Chlorofluor Gel used to treat the patients, as well as from unopened containers in the same batch, were contaminated with high levels of B. cepacia.  The contamination was found in all bottle sizes of the formula from the same batch.

The medicines watchdog said that although the bacterium posed little threat to healthy people, those with weakened immune systems, such as intensive care patients, might be more susceptible to infection and “at increased risk of associated health problems”.

“The effects of B. cepacia infection vary widely, ranging from no symptoms at all to serious respiratory infections, especially in patients with chronic lung diseases, such as cystic fibrosis,” the regulator said.

Chlorofluor Gel can be purchased over-the-counter, and those with products from the contaminated batch have been advised to return it to the place of purchase to get a refund, or to call Professional Dentist Supplies on 03 9761 6615 to arrange for the affected product to be collected and receive a refund.

Doctors treating patients who have used Chlorofluor Gel and who are showing signs of infection are being advised to include potential exposure to B. cepacia in clinical notes accompanying a pathology referral. The TGA said a test was unnecessary if patients were showing no signs of infection.

Adrian Rollins

[Comment] Caesarean section surgical techniques: all equally safe

Since 1985, a caesarean section rate of 10–15% has been deemed optimum by the international health-care community.1 When caesarean section rates rise towards 10% across a population, maternal and newborn deaths decrease; when they are higher than 15%, there is no evidence of reduced mortality.1 Complications of caesarean sections can be substantial and sometimes permanent for both mothers and babies, and can result in disability or death, especially in settings with inadequate facilities or capacity to undertake safe surgery and treat surgical complications.

News

AMA award winners presented at national conference

At the recent AMA National Conference the following awards were presented: AMA President’s Award in recognition of outstanding contributions to the care of their fellow Australians — Dr Paul Bauert, who for 30 years has fought for better care for Indigenous Australians and, more recently, children in immigration detention, and Vietnam War veteran Dr Graeme Killer, who has devoted his life to improve the care of current and retired Defence Force personnel; Doctor in Training of the Year Award for outstanding leadership, advocacy, and accomplishments of a doctor in training — Dr Ruth Mitchell, a neurosurgery trainee currently in her second year of her PhD at the University of Melbourne, and a neurosurgery registrar at the Royal Melbourne Hospital, and chair of the Royal Australasian College of Surgeons’ Trainee Association; Woman in Medicine Award, presented to a woman who has made a major contribution to the medical profession by showing ongoing commitment to quality care, or through her contribution to medical research, public health projects or improving the availability and accessibility of medical education and medical training for women — Associate Professor Diana Egerton-Warburton, in recognition of her exceptional contribution to the development of emergency medicine, and her passion for public health; Excellence in Healthcare Award recognises ongoing commitment to quality health and medical care, policy, and research, and is awarded to an individual or individuals who have made a significant contribution to improving health or healthcare in Australia — Associate Professor John Boffa and Ms Donna Ah Chee, who have made an enormous contribution to reducing harms of alcohol and improving early childhood outcomes for Aboriginal children.